Director of Scientific Programs – Rivkin Center for Ovarian Cancer, Nov 2016 – present

Post-doctoral Research Fellow – Fred Hutchinson Cancer Research Center, Sept 2008 – Nov 2016
Advisor: Dr. Toshiyasu Taniguchi, Human Biology Division
Understanding mechanisms of cisplatin-resistance in BRCA1-deficient cancer cells

Doctoral Research – University of Washington, April 2002 – June 2008.
Advisor: Dr. Raymond Monnat, Jr., Department of Genome Sciences
Analyzed in vivo functions of the Werner syndrome RecQ helicase protein (WRN) using   shRNA-mediated knockdown in human fibroblasts. Characterized cell phenotype of WRN-deficient mouse ear fibroblasts and human fibroblasts as a function of oxygen tension.

Graduate Rotation—University of Washington, Jan – Mar 2002.
Advisor: Dr. Mary-Claire King, Department of Genome Sciences
Carried out linkage analysis to identify the gene responsible for inherited deafness in a large family from Newfoundland, Canada

Graduate Rotation—University of Washington, Aug – Dec 2001.
Advisor: Dr. Carol Sibley, Department of Genome Sciences
Carried out mutation analysis to determine mutations in the Plasmodium falciparum dihydrofolate reductase gene that would confer resistance to multiple anti-malarial drugs



American Association for the Advancement of Science (AAAS), Member

American Society for Clinical Oncology (ASCO), Member

American Society of Human Genetics (ASHG), Past Member



Ph.D. in Genetics, University of Washington, Seattle, WA, June 2008

B.S. in Biology, Western Washington University, Bellingham, WA, Spring 1998

A.A.S. via Running Start, Whatcom Community College, Bellingham, WA, Summer 1996

Scientist, Communicator, Innovator